Vir Biotechnology Inc (NASDAQ:VIR) currently has a daily average trading volume of 1.34M but it saw 1292257 shares traded in last market. With a market cap of 637.28M USD, the company’s current market price of $4.61 came rising about 2.22 while comparing to the previous closing price of $4.51. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.45 and as low as $4.32.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the JP Morgan which downgraded the stock as “Neutral” in its note to investors issued on January 29, 2024, recommending a price target of between $23 and $9 for it. BofA Securities downgraded its recommendation for the stock as a “Neutral” from “Buy” on September 08, 2023 while assigning a price target range of $23-$14. JP Morgan issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $35 and $34.
Over the week, VIR’s stock price is moving 1.32% up while it is -22.78% when we observe its performance for the past one month. Year-to-date it is -37.19% down and over the past year, the stock is showing a downside performance of -52.43%.
Currently, Vir Biotechnology Inc’s total number of outstanding shares is 138.06M with 22.66% of that held by the insiders while 79.23% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -51.03% and return on equity (ROE) at -44.59%. Stock’s beta reads 1.25. Stock has a price to book (P/B) ratio of 0.61 while price to sale or P/S ratio amounts to 30.55. Its return on asset (ROA) is -37.25% on average.
